Marino, Stram & Associates LLC Biogen Inc. Transaction History

Marino, Stram & Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$282.99 - $369.05 $296,573 - $386,764	-1,048 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$259.0 - $414.71 $271,432 - $434,616	1,048 New	1,048 $362,000
Q2 2019 Jul 19, 2019	SELL	$219.29 - $241.72 $8,552 - $9,427	-39 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $433 - $677	2 Added 5.41%	39 $9,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $10,859 - $14,201	37 New	37 $13,000

999

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Marino, Stram & Associates LLC with notifications on news.